|
|
| Phases of Development | Phase I | Phase I/II | Phase II | Phase III | Marketed |
|---|
| Autoimmune | 1 | 1 | 2 | 0 | 0 | | Cancer | 0 | 0 | 1 | 0 | 1 | | Hematology | 0 | 0 | 0 | 1 | 0 | | Inflammation | 1 | 1 | 1 | 0 | 0 |
|
|
Products Targeting Granulocyte macrophage colony-stimulating factor (GM-CSF) receptor (CSF2RA) (GMR) (CD116)